Article
Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy.
The American journal of medicine - 1 Jun 1992
Massarotti E M, Liu N Y, Mier J, Atkins M B
Abstract excerpt
Interleukin-2 (IL-2) immunotherapy resulted in the development of inflammatory arthritis in three male patients with metastatic cancer. Two patients developed a clinical picture consistent with rheumatoid arthritis. A third patient with a remote history of Reiter's syndrome developed a recrudescence of an inflammatory arthritis after treatment with IL-2. The clinical, laboratory, and histologic data on the...
Topics
- Adult
- Antibodies, Antinuclear
- Arthritis
- Arthritis, Reactive
- Biopsy
- Histocompatibility Testing
- Humans
- Interleukin-2
- Male
- Middle Aged
- Neoplasms
- Phenotype